Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and ... Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders. Mehr anzeigen
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...
– First patient dosed in May 2024 in Phase 2 TRANQUILITY trial evaluating pacibekitug (TOUR006) in patients with high cardiovascular risk – – On track to initiate a pivotal Phase 3 trial...
Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability, and pharmacokinetics (PK) of quarterly and monthly subcutaneous...
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2.32 | 10.2973812694 | 22.53 | 25.88 | 21.69 | 438290 | 23.78424877 | CS |
| 4 | 7.59 | 43.9745075319 | 17.26 | 25.88 | 15.2354 | 247413 | 21.17078087 | CS |
| 12 | 12.03 | 93.8377535101 | 12.82 | 25.88 | 12.12 | 172387 | 18.00655267 | CS |
| 26 | 0.99 | 4.14920368818 | 23.86 | 25.88 | 12.12 | 269345 | 16.70309303 | CS |
| 52 | 14.53 | 140.794573643 | 10.32 | 48.31 | 9.18 | 258163 | 22.59720713 | CS |
| 156 | 14.53 | 140.794573643 | 10.32 | 48.31 | 9.18 | 258163 | 22.59720713 | CS |
| 260 | 14.53 | 140.794573643 | 10.32 | 48.31 | 9.18 | 258163 | 22.59720713 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
